Yes, Retest Both Vitamin D and B12 Levels Now
Given your history of vitamin D and B12 deficiency combined with possible Crohn's disease, you should have both serum 25-hydroxyvitamin D and serum vitamin B12 levels rechecked immediately. This is not optional—it's a critical part of your diagnostic workup and ongoing management.
Why This Testing Is Essential
Vitamin D Monitoring in Crohn's Disease
The British Society of Gastroenterology 2019 guidelines explicitly state that "vitamin D status should be routinely measured in IBD" 1. This recommendation is particularly important in your situation because:
- Prevalence is extremely high: 53% of Crohn's disease patients have vitamin D deficiency (defined as 25-OH-D <50 nmol/L or <20 ng/mL) 1
- Disease activity correlation: Vitamin D concentrations are inversely associated with disease activity—lower levels correlate with more active disease 1, 2, 3
- Clinical outcomes matter: Low vitamin D is associated with increased risk of surgery, hospitalizations, and reduced response to anti-TNF therapy 4
- Bone health: Vitamin D deficiency is associated with low bone mineral density, a significant concern in IBD patients 1, 4
Your prior deficiency makes you even higher risk, and establishing a baseline now is crucial before any treatment decisions are made.
Vitamin B12 Monitoring in Crohn's Disease
The 2024 AGA Clinical Practice Update is unequivocal: "Patients with extensive ileal disease or prior ileal surgery should be monitored for vitamin B12 deficiency" 5. Even without confirmed Crohn's yet, testing is warranted because:
- High prevalence: 15.6% of Crohn's disease patients have B12 deficiency (compared to only 2.8% in ulcerative colitis) 6
- Ileal involvement: The terminal ileum—commonly affected in Crohn's—is where B12 is specifically absorbed 7
- Prior deficiency: Your history of B12 deficiency suggests either dietary insufficiency or possible malabsorption, making retesting essential 6
- Clinical consequences: B12 deficiency can cause macrocytic anemia, neurological complications, and is associated with thrombosis risk 7
The BSG guidelines specifically recommend "vitamin B12 monitoring" as part of standard IBD care 1 and advise considering B12 deficiency when evaluating anemia in IBD patients 1.
The Clinical Algorithm
Step 1: Test Now
- Order serum 25-hydroxyvitamin D [25(OH)D]
- Order serum vitamin B12 (cobalamin)
- Consider adding folate, complete blood count, and inflammatory markers (CRP, ESR) for comprehensive assessment 1
Step 2: Interpret Results in Context
- Vitamin D deficiency: <20 ng/mL (<50 nmol/L) 1, 4
- B12 deficiency: <200 pg/mL 6
- Note: Inflammatory markers can affect interpretation—CRP should be <10 mg/L for reliable vitamin D assessment 1
Step 3: Establish Baseline Before Diagnosis This is critical because once Crohn's is confirmed, you'll need:
- Regular annual monitoring of both vitamins 4, 5
- More frequent monitoring (every 3-6 months) after dosage changes 4
- Ongoing supplementation adjusted to maintain optimal levels
Important Caveats
Don't wait for Crohn's confirmation: The guidelines recommend nutritional assessment and screening at each clinic appointment for IBD patients 1, but your prior deficiencies justify testing now regardless of final diagnosis.
Vitamin D has dual importance: Beyond bone health, there's emerging evidence (though not yet definitive) that adequate vitamin D may influence disease course and treatment response 1, 4. A small RCT showed a trend toward reduced relapse rates with supplementation (13% vs 29%, p=0.06) 1.
B12 monitoring becomes mandatory if: You have >20 cm of distal ileum involved or resected, or if deficiency is documented 8. Since you don't know your disease extent yet, establishing baseline is prudent.
Quality of life impact: Both deficiencies cause fatigue and affect recovery 1, symptoms that overlap with IBD and can be easily corrected if identified.
Bottom Line
Retest both levels now. This serves three purposes: (1) identifies current deficiencies requiring immediate correction, (2) establishes your baseline for future monitoring, and (3) provides prognostic information about potential disease activity if Crohn's is confirmed. The evidence consistently shows these are not optional tests—they're standard of care in IBD evaluation and management 1, 4, 5, 8.